The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2023
Filed:
Jul. 22, 2020
Applicant:
Renascience Co., Ltd., Tokyo, JP;
Inventor:
Toshio Miyata, Miyagi, JP;
Assignee:
RENASCIENCE CO., LTD., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/51 (2006.01); A61K 31/4415 (2006.01); A61K 31/44 (2006.01); A61P 13/12 (2006.01); A61P 3/02 (2006.01); A61P 25/32 (2006.01); A61P 3/10 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 25/18 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/51 (2013.01); A61K 31/44 (2013.01); A61K 31/4415 (2013.01); A61P 3/02 (2018.01); A61P 3/10 (2018.01); A61P 13/12 (2018.01); A61P 19/10 (2018.01); A61P 25/18 (2018.01); A61P 25/32 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01);
Abstract
Vitamin B1 deficiency caused when a pyridoxamine compound is administered in a large amount is prevented and/or treated. A pharmaceutical composition formed by combining at least one pyridoxamine compound selected from the group consisting of pyridoxamine and pharmaceutically acceptable salts thereof and at least one thiamine compound selected from the group consisting of thiamine, derivatives thereof, and pharmaceutically acceptable salts thereof, is administered.